Proteomics Prove Accurate in Identifying Liver Cancerby (author unknown), Harvard Medical Research: Cancer overview on Feb 22, 2008A novel mass-spectrometry based form of proteomic profiling is more accurate than traditional biomarkers in distinguishing liver cancer patients from patients with hepatitis C liver cirrhosis, particularly with regard to identifying patients with small, curable tumors.
Be the first to comment on this article.
Add a commentPlease do not include any advertisements or offensive material. cancel |
